We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
93 hedge funds and large institutions have $66M invested in Invesco Pharmaceuticals ETF in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
129% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 7
18% more capital invested
Capital invested by funds: $56.1M → $66M (+$9.97M)
8% more funds holding
Funds holding: 86 → 93 (+7)
2.53% more ownership
Funds ownership: 21.23% → 23.76% (+2.5%)
8% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 25
Holders
93
Holders Change
+7
Holders Change %
+8.14%
% of All Funds
1.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
23
Reduced
25
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
LPL Financial
San Diego,
California
|
+$3.23M |
| 2 |
GAA
Global Assets Advisory
Orlando,
Florida
|
+$2.47M |
| 3 |
FGA
Fortis Group Advisors
Westwood,
New Jersey
|
+$2M |
| 4 |
QAM
Q3 Asset Management
Birmingham,
Michigan
|
+$1.05M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$820K |
Top Sellers
| 1 |
CRI
Commonwealth Retirement Investments
Richmond,
Virginia
|
-$1.56M |
| 2 |
Morgan Stanley
New York
|
-$1.27M |
| 3 |
JGCM
Joseph Group Capital Management
Columbus,
Ohio
|
-$1.25M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$845K |
| 5 |
EH
Equitable Holdings
New York
|
-$243K |
